Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein
S. M. Johnson, Hanmei Bao, Cailin E. McMahon, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
Norbert Stefan, Hannele Yki‐Järvinen, Brent A. Neuschwander‐Tetri
The Lancet Diabetes & Endocrinology (2024)
Open Access | Times Cited: 19
FSP1-mediated lipid droplet quality control prevents neutral lipid peroxidation and ferroptosis
Mike Lange, Michele Wölk, Cody E. Doubravsky, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 4
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: two randomized phase I trials
Javier Armisen, Mitra Rauschecker, Janeli Sarv, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 4
Integrative Metabolism in MASLD and MASH: Pathophysiology and Emerging Mechanisms
Gregory R. Steinberg, Celina M Valvano, William De Nardo, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 2
PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis
Yang Wang, Sen Hong, Hannah Hudson, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 9
Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome—An Update
Imadeldin Elfaki, Rashid Mir, Mohamed E. Elnageeb, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 83-83
Open Access | Times Cited: 1
Lipid droplet targeting of the lipase co-activator ABHD5 and the fatty liver disease-causing variant PNPLA3 I148M is required to promote liver steatosis
Grace Teskey, Nivedita Tiwari, Andrew J Butcko, et al.
Journal of Biological Chemistry (2025), pp. 108186-108186
Closed Access | Times Cited: 1
Sex‐specific effects of PNPLA3 I148M
Alessandro Cherubini, Chiara Rosso, Sara Della Torre
Liver International (2024)
Open Access | Times Cited: 5
Loss or gain of function: The functional complexity of the PNPLA3 I148M Variant
Sepideh Mikaeeli, David E. Cohen
Journal of Hepatology (2025)
Closed Access
Function of PNPLA3 I148M—Lessons From In Vivo Studies in Humans
Hannele Yki‐Järvinen, Panu K. Luukkonen
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Association between single nucleotide polymorphisms in PNPLA3, TM6SF2 and MBOAT7 genes and markers of cancer aggressiveness in a Sri Lankan NASH-related HCC cohort
Saumya Madushani Samarasinghe, Asanka Sudeshini Hewage, R. C. Siriwardana, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH
William De Nardo, Olivia W. Lee, Yazmin Johari, et al.
Cell Reports Medicine (2025), pp. 102085-102085
Open Access
Analyzing the Cholesteryl Ester Fraction in Lipid Droplets with a Polarity-Ultrasensitive Fluorescence Lifetime Probe
Sijia Lü, Yanyan Zhao, Diankai Liu, et al.
Analytical Chemistry (2025)
Closed Access
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis
Ikki Sakuma, Rafael Calais Gaspar, Ali Nasiri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Visfatin (rs3801266) and Adiponutrin (rs738409) gene single nucleotide polymorphisms in patients with Hashimoto’s thyroiditis
M. Ahmed, Eman Badr, Mohamed FA. Assar
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Key genes and processes affected by atorvastatin treatment in mouse diaphragm muscle
Guzel F. Zakyrjanova, Valeriya A Matigorova, Eva A. Kuznetsova, et al.
Archives of Toxicology (2025)
Closed Access
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitis
Ikki Sakuma, Rafael Calais Gaspar, Ali Nasiri, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 18
Open Access
PNPLA3 I148M variant links to adverse metabolic traits in MASLD during fasting and feeding☆
Lina Jegodzinski, Lorena Rudolph, Darko Castven, et al.
JHEP Reports (2025), pp. 101450-101450
Open Access
Targeting acetyl-CoA carboxylases for the treatment of MASLD
María Antonia Mateo-Marín, Michele Alves‐Bezerra
Journal of Lipid Research (2024), pp. 100676-100676
Open Access | Times Cited: 3
Lipoprotein Lipidomics as a Frontier in Non-Alcoholic Fatty Liver Disease Biomarker Discovery
Luis V. Herrera‐Marcos, José M. Arbones-Mainar, Jesús Osada
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8285-8285
Open Access | Times Cited: 2
Exercise-regulated lipolysis: Its role and mechanism in health and diseases
Jieying Zhu, Liang Guo
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
PNPLA3(148M) promotes hepatic steatosis by interfering with triglyceride hydrolysis through a gain-of-function mechanism
Yang Wang, Sen Hong, Hannah Hudson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk
Maria Castanho Martins, Emmanuel Dauda Dixon, Giulia Lupo, et al.
Liver International (2024)
Open Access | Times Cited: 1
Lipid availability influences ferroptosis sensitivity in cancer cells by regulating polyunsaturated fatty acid trafficking
Kelly H. Sokol, Cameron J. Lee, Thomas J. Rogers, et al.
Cell chemical biology (2024)
Open Access | Times Cited: 1
Targeting PNPLA3 to Treat MASH and MASH Related Fibrosis and Cirrhosis
Daniel Lindén, Gregory J. Tesz, Rohit Loomba
Liver International (2024)
Closed Access | Times Cited: 1
Page 1

Scroll to top